Legal Representation
Attorney
Cathy A. Kodroff
USPTO Deadlines
Next Deadline
514 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20210622)
Due Date
June 22, 2027
Grace Period Ends
December 22, 2027
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
15 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jun 22, 2021 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Apr 6, 2021 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Apr 6, 2021 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Mar 17, 2021 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Mar 1, 2021 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Feb 25, 2021 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Feb 25, 2021 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Feb 25, 2021 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Nov 24, 2020 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Jun 3, 2020 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Jun 3, 2020 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Jun 3, 2020 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| May 27, 2020 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Mar 12, 2020 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Mar 10, 2020 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations, namely, beta-Hydroxy beta-methylglutaryl-CoA (HMG-CoA) reductase inhibitors used to lower LDL cholesterol and to treat hypertriglyceridemia as an adjunct to diet; cholesterol lowering medications; pharmaceutical preparations that act as central nervous system stimulants; pharmaceutical preparations, namely, neuromodulators for treatment of psychiatric disorders and disorders related to attention-deficit hyperactivity disorder; pharmaceutical preparations for the treatment of attention-deficit hyperactivity disorder (ADHD); liquid oral pharmaceutical preparations for the treatment of attention-deficit hyperactivity disorder (ADHD); solid pharmaceutical preparations for the treatment of attention-deficit hyperactivity disorder (ADHD); pharmaceutical preparations for the treatment of narcolepsy; pharmaceutical preparations for the treatment of chronic lung disease; pharmaceutical preparations for the treatment of colds; pharmaceutical preparations for the treatment of coughs; extended release liquid pharmaceutical preparations for the treatment of coughs; pharmaceutical preparations for the treatment of upper respiratory symptoms; pharmaceutical preparations for the treatment of pain
First Use Anywhere:
Jan 1, 2015
First Use in Commerce:
Jan 1, 2015
Class 044
Providing information relating to therapeutic properties of pharmaceutical preparations; providing a website featuring information relating to therapeutic properties of pharmaceutical preparations
First Use Anywhere:
Jan 1, 2017
First Use in Commerce:
Jan 1, 2017
Classification
International Classes
005
044